Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion

Journal of Experimental Medicine

Volumn 213, Issue 9, 2016, Pages 1881-1900

  Chopra, Martin ^a,b,h   Biehl, Marlene ^a,b   Steinfatt, Tim ^a,b   Brandl, Andreas ^a,b   Kums, Juliane ^a   Amich, Jorge ^a,b   Vaeth, Martin ^b,i   Kuen, Janina ^b   Holtappels, Rafaela ^d   Podlech, Jürgen ^d   Mottok, Anja ^b,j   Kraus, Sabrina ^a,b   Jordán Garrote, Ana Laura ^a,b   Bäuerlein, Carina A ^a,b   Brede, Christian ^a,b   Ribechini, Eliana ^b   Fick, Andrea ^a   Seher, Axel ^a   Polz, Johannes ^e   Ottmüller, Katja J ^a,b   Baker, Jeanette ^f   Nishikii, Hidekazu ^f   Ritz, Miriam ^a,b   Mattenheimer, Katharina ^a,b   Schwinn, Stefanie ^a,b   Winter, Thorsten ^a,b   Schäfer, Viktoria ^a   Krappmann, Sven ^g   Einsele, Hermann ^a   Müller, Thomas D ^c   Reddehase, Matthias J ^d   Lutz, Manfred B ^b   Männel, Daniela N ^e   Berberich Siebelt, Friederike ^b   Wajant, Harald ^a   Beilhack, Andreas ^a,b   more..

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h UNIVERSITY OF AUCKLAND   (New Zealand)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BRITISH COLUMBIA CANCER AGENCY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR AGONIST; STAR2 AGONIST; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; INTERLEUKIN 2;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOREACTIVE T CELL; ANIMAL EXPERIMENT; ARTICLE; CELL EXPANSION; GRAFT RECIPIENT; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MIXED CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLENIC T CELL; SURVIVAL; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; ACUTE DISEASE; ANIMAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; INBRED MOUSE STRAIN; MYELOID-DERIVED SUPPRESSOR CELL; PHYSIOLOGY;

ACUTE DISEASE; ANIMALS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INTERLEUKIN-2; MICE; MICE, INBRED STRAINS; MYELOID-DERIVED SUPPRESSOR CELLS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES, REGULATORY;

EID: 84984829560     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151563     Document Type: Article

References (62)

1. + T cells that survive irradiation regulate chronic graft-versus-host disease. Blood. 104:1565-1573. http://dx.doi.org/10.1182/blood -2004-01-0328
2. Ban, L., W. Kuhtreiber, J. Butterworth, Y. Okubo, É.S. Vanamee, and D.L. Faustman. 2015. Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling. Mol. Cell. Ther. 3:7. http://dx.doi.org/10.1186/s40591-015-0044-4
3. Beilhack, A., S. Schulz, J. Baker, G.F. Beilhack, C.B. Wieland, E.I. Herman, E.M. Baker, Y.A. Cao, C.H. Contag, and R.S. Negrin. 2005. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 106:1113-1122. http://dx.doi.org/10.1182/blood -2005-02-0509
4. Beilhack, A., S. Schulz, J. Baker, G.F. Beilhack, R. Nishimura, E.M. Baker, G. Landan, E.I. Herman, E.C. Butcher, C.H. Contag, and R.S. Negrin. 2008. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood. 111:2919-2928. http://dx.doi.org/10.1182/blood -2007-09-112789
5. Brunstein, C.G., J.S. Miller, Q. Cao, D.H. McKenna, K.L. Hippen, J. Curtsinger, T. Defor, B.L. Levine, C.H. June, P. Rubinstein, et al. 2011. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 117:1061-1070. http://dx.doi.org/10.1182/blood -2010-07-293795
6. Casares, N., F. Rudilla, L. Arribillaga, D. Llopiz, J.I. Riezu-Boj, T. Lozano, J. López-Sagaseta, L. Guembe, P. Sarobe, J. Prieto, et al. 2010. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J. Immunol. 185:5150-5159. http://dx.doi.org/10.4049/jimmunol.1001114
7. + T regulatory cells. J. Immunol. 179:154-161. http://dx.doi.org/10.4049/jimmunol.179.1.154
8. + T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 180:6467-6471. http://dx.doi.org/10.4049/jimmunol.180.10.6467
9. + regulatory T cells. J. Immunol. 185:174-182. http://dx.doi.org/10.4049/jimmunol.0903548
10. + regulatory T cells in human peripheral blood. Eur. J. Immunol. 40:1099-1106. http://dx.doi.org/10.1002/eji.200940022
11. + regulatory T. cell phenotype in the inflammatory environment. J. Immunol. 190:1076-1084. http://dx.doi.org/10.4049/jimmunol.1202659
12. Chopra, M., S. Kraus, S. Schwinn, M. Ritz, K. Mattenheimer, A. Mottok, A. Rosenwald, H. Einsele, and A. Beilhack. 2013b. Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantation. PLoS One. 8:e81320. http://dx.doi.org/10.1371/journal.pone.0081320
13. Chopra, M., S.S. Riedel, M. Biehl, S. Krieger, V. von Krosigk, C.A. Bäuerlein, C. Brede, A.L. Jordan Garrote, S. Kraus, V. Schäfer, et al. 2013a. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis. Carcinogenesis. 34:1296-1303. http://dx.doi.org/10.1093/carcin/bgt038
14. Chopra, M., A. Brandl, D. Siegmund, A. Mottok, V. Schäfer, M. Biehl, S. Kraus, C.A. Bäuerlein, M. Ritz, K. Mattenheimer, et al. 2015. Blocking TWE AK-Fn14 interaction inhibits hematopoietic stem cell transplantationinduced intestinal cell death and reduces GVHD. Blood. 126:437-444. http://dx.doi.org/10.1182/blood -2015-01-620583
15. Coghill, J.M., M.J. Carlson, A. Panoskaltsis-Mortari, M.L. West, J.E. Burgents, B.R. Blazar, and J.S. Serody. 2010. Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells. Blood. 115:4914-4922. http://dx.doi.org/10.1182/blood -2009-08-239848
16. Cooke, K.R., L. Kobzik, T.R. Martin, J. Brewer, J. Delmonte Jr., J.M. Crawford, and J.L. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 88:3230-3239.
17. Di Ianni, M., F. Falzetti, A. Carotti, A. Terenzi, F. Castellino, E. Bonifacio, B. Del Papa, T. Zei, R.I. Ostini, D. Cecchini, et al. 2011. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 117:3921-3928. http://dx.doi.org/10.1182/blood -2010-10-311894
18. Edinger, M., and P. Hoffmann. 2011. Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr. Opin. Immunol. 23:679-684. http://dx.doi.org/10.1016/j.coi.2011.06.006
19. + regulatory T cells preserve graftversus- tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9:1144-1150. http://dx.doi.org/10.1038/nm915
20. Ehrenstein, M.R., J.G. Evans, A. Singh, S. Moore, G. Warnes, D.A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200:277-285. http://dx.doi.org/10.1084/jem.20040165
21. Feldmann, M., and R.N. Maini. 2003. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9:1245-1250. http://dx.doi.org/10.1038/nm939
22. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:793-802. http://dx.doi.org/10.1016/0092-8674(95)90192-2
23. Grinberg-Bleyer, Y., D. Saadoun, A. Baeyens, F. Billiard, J.D. Goldstein, S. Grégoire, G.H. Martin, R. Elhage, N. Derian, W. Carpentier, et al. 2010. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J. Clin. Invest. 120:4558-4568. http://dx.doi.org/10.1172/JCI42945
24. Hebart, H., and H. Einsele. 2004. Clinical aspects of CMV infection after stem cell transplantation. Hum. Immunol. 65:432-436. http://dx.doi.org/10.1016/j.humimm.2004.02.022
25. + regulatory T cells suppress lethal acute graftversus- host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196:389-399. http://dx.doi.org/10.1084/jem.20020399
26. Housley, W.J., C.O. Adams, F.C. Nichols, L. Puddington, E.G. Lingenheld, L. Zhu, T.V. Rajan, and R.B. Clark. 2011. Natural but not inducible regulatory T cells require TNF-α signaling for in vivo function. J. Immunol. 186:6779-6787. http://dx.doi.org/10.4049/jimmunol.1003868
27. Jones, S.C., G.F. Murphy, and R. Korngold. 2003. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol. Blood Marrow Transplant. 9:243-256. http://dx.doi.org/10.1053/bbmt.2003.50027
28. Kim, Y.M., T. Sachs, W. Asavaroengchai, R. Bronson, and M. Sykes. 2003. Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J. Clin. Invest. 111:659-669. http://dx.doi.org/10.1172/JCI200316950
29. Klages, K., C.T. Mayer, K. Lahl, C. Loddenkemper, M.W. Teng, S.F. Ngiow, M.J. Smyth, A. Hamann, J. Huehn, and T. Sparwasser. 2010. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res. 70:7788-7799. http://dx.doi.org/10.1158/0008-5472.CAN -10-1736
30. Ko, J.M., A.B. Gottlieb, and J.F. Kerbleski. 2009. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J. Dermatolog. Treat. 20:100-108. http://dx.doi.org/10.1080/09546630802441234
31. Komatsu, N., and S. Hori. 2007. Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc. Natl. Acad. Sci. USA. 104:8959-8964. http://dx.doi.org/10.1073/pnas.0702004104
32. Levine, J.E. 2011. Implications of TNF-α in the pathogenesis and management of GVHD. Int. J. Hematol. 93:571-577. http://dx.doi.org/10.1007/s12185-011-0803-1
33. Lewis, M., L.A. Tartaglia, A. Lee, G.L. Bennett, G.C. Rice, G.H. Wong, E.Y. Chen, and D.V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA. 88:2830-2834. http://dx.doi.org/10.1073/pnas.88.7.2830
34. Li, H.W., and M. Sykes. 2012. Emerging concepts in haematopoietic cell transplantation. Nat. Rev. Immunol. 12:403-416. http://dx.doi.org/10.1038/nri3226
35. high T-regulatory cells in allergic asthma is subjected to TNF-α modulation. Allergy. 63:67-74. http://dx.doi.org/10.1111/j.1398-9995.2007.01526.x
36. Loetscher, H., D. Stueber, D. Banner, F. Mackay, and W. Lesslauer. 1993. Human tumor necrosis factor α (TNF α) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem. 268:26350-26357.
37. Marr, K.A., R.A. Carter, M. Boeckh, P. Martin, and L. Corey. 2002. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 100:4358-4366. http://dx.doi.org/10.1182/blood -2002-05-1496
38. Martelli, M.F., M. Di Ianni, L. Ruggeri, F. Falzetti, A. Carotti, A. Terenzi, A. Pierini, M.S. Massei, L. Amico, E. Urbani, et al. 2014. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood. 124:638-644. http://dx.doi.org/10.1182/blood -2014-03-564401
39. Miller, P.G., M.B. Bonn, and S.C. McKarns. 2015. Transmembrane TNFTNFR2 impairs Th17 differentiation by promoting IL2 expression. J. Immunol. 195:2633-2647. http://dx.doi.org/10.4049/jimmunol.1500286
40. Nadkarni, S., C. Mauri, and M.R. Ehrenstein. 2007. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204:33-39. http://dx.doi.org/10.1084/jem.20061531
41. - regulatory T cells that modulates their suppressive function. J. Immunol. 184:3570-3581. http://dx.doi.org/10.4049/jimmunol.0902070
42. Nguyen, V.H., R. Zeiser, D.L. Dasilva, D.S. Chang, A. Beilhack, C.H. Contag, and R.S. Negrin. 2007. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood. 109:2649-2656. http://dx.doi.org/10.1182/blood -2006-08-044529
43. Nie, H., Y. Zheng, R. Li, T.B. Guo, D. He, L. Fang, X. Liu, L. Xiao, X. Chen, B. Wan, et al. 2013. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat. Med. 19:322-328. http://dx.doi.org/10.1038/nm.3085
44. Okubo, Y., T. Mera, L. Wang, and D.L. Faustman. 2013. Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2. Sci. Rep. 3:3153. http://dx.doi.org/10.1038/srep03153
45. Pierini, A., L. Colonna, M. Alvarez, D. Schneidawind, H. Nishikii, J. Baker, Y. Pan, M. Florek, B.S. Kim, and R.S. Negrin. 2015. Donor requirements for regulatory T cell suppression of murine graft-versus-host disease. J. Immunol. 195:347-355. http://dx.doi.org/10.4049/jimmunol.1402861
46. Podlech, J., R. Holtappels, M.F. Pahl-Seibert, H.P. Steffens, and M.J. Reddehase. 2000. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J. Virol. 74:7496-7507. http://dx.doi.org/10.1128/JVI.74.16.7496-7507.2000
47. Podlech, J., R. Holtappels, N.K.A. Grzimek, and M.J. Reddehase. 2002. Animal models: murine cytomegalovirus. In Immunology of Infection. S.H.E. Kaufmann and D. Kabelitz, editors. Academic Press, San Diego. 493-525. http://dx.doi.org/10.1016/S0580-9517(02)32103-2
48. Ramos-Casals, M., P. Brito-Zerón, M.J. Soto, M.J. Cuadrado, and M.A. Khamashta. 2008. Autoimmune diseases induced by TNF-targeted therapies. Best Pract. Res. Clin. Rheumatol. 22:847-861. http://dx.doi.org/10.1016/j.berh.2008.09.008
49. Rauert, H., A. Wicovsky, N. Müller, D. Siegmund, V. Spindler, J. Waschke, C. Kneitz, and H. Wajant. 2010. Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem. 285:7394-7404. http://dx.doi.org/10.1074/jbc. M109.037341
50. Robinson, W.H., M.C. Genovese, and L.W. Moreland. 2001. Demyelinating and neurologic events reported in association with tumor necrosis factor α antagonism: by what mechanisms could tumor necrosis factor α antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum. 44:1977-1983. http://dx.doi.org/10.1002/1529-0131(200109)44 :9<1977::AID-ART345>3.0.CO;2-6
51. Römer, P.S., S. Berr, E. Avota, S.Y. Na, M. Battaglia, I. ten Berge, H. Einsele, and T. Hünig. 2011. Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood. 118:6772-6782. http://dx.doi.org/10.1182/blood -2010-12-319780
52. Rubocki, R.J., T.H. Hansen, and D.R. Lee. 1986. Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2Ld gene. Proc. Natl. Acad. Sci. USA. 83:9606-9610. http://dx.doi.org/10.1073/pnas.83.24.9606
53. Schneidawind, D., A. Pierini, and R.S. Negrin. 2013. Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation. Blood. 122:3116-3121. http://dx.doi.org/10.1182/blood -2013-08-453126
54. Schneidawind, D., A. Pierini, M. Alvarez, Y. Pan, J. Baker, C. Buechele, R.H. Luong, E.H. Meyer, and R.S. Negrin. 2014. CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells. Blood. 124:3320-3328. http://dx.doi.org/10.1182/blood -2014-05-576017
55. Schneider, P., N. Holler, J.L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213. http://dx.doi.org/10.1084/jem.187.8.1205
56. + regulatory T cells in Foxp3.LuciDTR mice. J. Immunol. 184:1810-1820. http://dx.doi.org/10.4049/jimmunol.0902420
57. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112:1688-1696. http://dx.doi.org/10.1172/JCI17702
58. + Tregcell function and disease suppression in EAE. Eur. J. Immunol. 42:403-412. http://dx.doi.org/10.1002/eji.201141659
59. hi T-regulatory cells. Blood. 108:253-261. http://dx.doi.org/10.1182/blood -2005-11-4567
60. Veerapathran, A., J. Pidala, F. Beato, B. Betts, J. Kim, J.G. Turner, M.K. Hellerstein, X.Z. Yu, W. Janssen, and C. Anasetti. 2013. Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease. Blood. 122:2251-2261. http://dx.doi.org/10.1182/blood -2013-03-492397
61. Welniak, L.A., B.R. Blazar, and W.J. Murphy. 2007. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol. 25:139-170. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141606
62. Zhang, Q., F. Cui, L. Fang, J. Hong, B. Zheng, and J.Z. Zhang. 2013. TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway. J. Mol. Cell Biol. 5:85-98. http://dx.doi.org/10.1093/jmcb/mjs063